Global Eye Health Supplements Market is anticipated to rise at a value CAGR of 10.9 % over 2019-2028. Eye Health Supplements are those supplements that are being used to improve eye vision by providing essential nutrients required to the eyes. It includes nutrients like Lutein, Zeaxanthin, Omega 3 fatty acids, etc. It is being used in cases like Age-Related Macular Degeneration (AMD), Glaucoma, Diabetic Retinopathy, etc. Ongoing product launches by the competitors and innovation for providing better eye health are driving the market growth.
Top Driver: The surge in the population growth of people suffering from Vitamin A deficiency.
The surge in population growth, the rise in the geriatric population, and the increase in the number of individuals suffering from Vitamin A deficiency are primarily influencing the market. The rise in the prevalence of lifestyle habits like smoking has led to AMD (Age-Related Macular Degeneration)the continuous use of the smartphone has triggered the demand for Eye health supplements. The rise in the incidences of diseases like diabetes and an increase in government initiatives research activities have further escalated the growth of the market.
Lutein consists of anti-inflammatory properties and is essential to prevent age-related macular disease and thus is helpful in blindness and vision impairment and thus have improved its demand in the market
In terms of the Application, Age-Related Macular Degenerationsegment has obtained the most remarkable growth owing to the rise in the incidences of AMD, stress, high blood pressure, and lifestyle habits like smoking have further improved the growth. Based on the End User, the pharmacy stores segment has held the highest market growth owing to the high availability of various eye supplements in these stores.
, and Butterflies Healthcare Ltd
Novartis AG: Novartis AG, is one of the key competitors of the Global Eye Health Supplements Market; for instance, In April 2019, Novartis AG had announced that the FDA had accepted Novatis’sbiologics license application (BLA) for brolucizumab (RTH258) in the treatment of wet age-related macular degeneration (AMD) and thus Novartis will be shortly launching brolucizumab for AMD treatment.
Pfizer Inc.: Pfizer Inc. is a popular competitor in the Global Eye Health Supplements Market. In July 2019, Pfizer Inc had announced that it had completed the acquisition of Array BioPharma Inc. They are involved in the discovery, development of targeted small molecule medicines to treat cancer. The acquisition was made by Pfizer to strengthen its product portfolio with Oncology medicines like BRAFTOVI and MEKTOVI.
2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.
3. It renders a definite analysis for changing competitive dynamics.
4. It builds a seven-year estimate based on how the market is predicted to grow.
Top Driver: The surge in the population growth of people suffering from Vitamin A deficiency.
The surge in population growth, the rise in the geriatric population, and the increase in the number of individuals suffering from Vitamin A deficiency are primarily influencing the market. The rise in the prevalence of lifestyle habits like smoking has led to AMD (Age-Related Macular Degeneration)the continuous use of the smartphone has triggered the demand for Eye health supplements. The rise in the incidences of diseases like diabetes and an increase in government initiatives research activities have further escalated the growth of the market.
Lutein and Zeaxanthin have made the highest contribution in the Global Eye Health Supplements Market
Based on the Ingredient, Lutein and Zeaxanthinsegment have made the highest contribution in the market; they are used in order to protect and maintain healthy cells in the eyes by filtering harmful high-energy blue wavelengths.Lutein consists of anti-inflammatory properties and is essential to prevent age-related macular disease and thus is helpful in blindness and vision impairment and thus have improved its demand in the market
In terms of the Application, Age-Related Macular Degenerationsegment has obtained the most remarkable growth owing to the rise in the incidences of AMD, stress, high blood pressure, and lifestyle habits like smoking have further improved the growth. Based on the End User, the pharmacy stores segment has held the highest market growth owing to the high availability of various eye supplements in these stores.
North America dominated the GlobalEye Health Supplements Market
The rise in the incidences of chronic eye disorders and an increase in the geriatric population are primarily improving regional market growth. The favorable reimbursement scenario and an increase in awareness about eye health supplements are contributing to the regional growth of North America. Ongoing product launches and developments for the development of better eye products, an increase in research & development activities, and improvement in the insurance sectors, have escalated the regional revenue.Product Launches, new advances Strategic Collaborations, Mergers, and Acquisition, are the major strategies of the competitors
The Players of the Global Eye Health Supplements focuses on product launches, new advances collaborations, mergers, and acquisitions are the key strategies. The key competitors of the Global Eye Health Supplements Market are Vitabiotics Ltd., Pfizer Inc., Bausch Health Companies Inc., Novartis AG, Amway Corp., Alliance Pharma, The Nature's Bounty Co, Herbalife International of America, Inc., SUSS Technology Corp., and Butterflies Healthcare Ltd
Novartis AG: Novartis AG, is one of the key competitors of the Global Eye Health Supplements Market; for instance, In April 2019, Novartis AG had announced that the FDA had accepted Novatis’sbiologics license application (BLA) for brolucizumab (RTH258) in the treatment of wet age-related macular degeneration (AMD) and thus Novartis will be shortly launching brolucizumab for AMD treatment.
Pfizer Inc.: Pfizer Inc. is a popular competitor in the Global Eye Health Supplements Market. In July 2019, Pfizer Inc had announced that it had completed the acquisition of Array BioPharma Inc. They are involved in the discovery, development of targeted small molecule medicines to treat cancer. The acquisition was made by Pfizer to strengthen its product portfolio with Oncology medicines like BRAFTOVI and MEKTOVI.
Scope of the Report
By Ingredient
- Lutein and Zeaxanthin
- Antioxidants
- Omega-3 Fatty Acids
- Coenzyme Q10
By Application
- Age-Related Macular Degeneration (AMD)
- Glaucoma
- Cataract
- Diabetic Retinopathy
By End-User
- Pharmacy
- Online Stores
By Region
- North America
- Europe
- Asia Pacific
- Rest Of World
Key Reasons to Purchase this Report
1. It provides a technological development map over time to understand the growth rate of the industry.2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.
3. It renders a definite analysis for changing competitive dynamics.
4. It builds a seven-year estimate based on how the market is predicted to grow.
Table of Contents
Chapter 1 Overview And Scope
Chapter 2 Our Research Practice
Chapter 3 Executive Summary
Chapter 4 Covid-19 Impact Analysis
Chapter 5 Global Eye Health Supplements Market Forces
Chapter 6 Global Eye Health Supplements Market -Industry Snapshots
Chapter 7 Global Eye Health Supplements Market Analysis, by Ingredient
Chapter 8 Global Eye Health Supplements Market Analysis, by Application
Chapter 9 Global Eye Health Supplements Market Analysis, by End User
Chapter 10 Eye Health Supplements Market Analysis by Region
Chapter 11 Market Competition Analysis
Chapter 12 Company Profiles- Snapshot
List of Figures
List of Tables
Methodology
LOADING...
